Bank Of New York Mellon Corp Bio Xcel Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$17.7 - $33.24 $1.37 Million - $2.56 Million	77,132 New	77,132 $1.44 Billion
Q4 2022 Feb 14, 2023	BUY	$10.25 - $22.43 $737,477 - $1.61 Million	71,949 New	71,949 $1.55 Million
Q3 2022 Nov 14, 2022	BUY	$11.19 - $17.89 $49,347 - $78,894	4,410 Added 7.25%	65,219 $771,000
Q2 2022 Aug 15, 2022	BUY	$9.03 - $21.55 $21,879 - $52,215	2,423 Added 4.15%	60,809 $802,000
Q1 2022 May 11, 2022	BUY	$15.0 - $22.83 $24,555 - $37,372	1,637 Added 2.88%	58,386 $1.22 Million
Q4 2021 Feb 11, 2022	BUY	$20.12 - $35.09 $51,869 - $90,462	2,578 Added 4.76%	56,749 $1.15 Million
Q3 2021 Nov 12, 2021	BUY	$23.84 - $32.03 $107,327 - $144,199	4,502 Added 9.06%	54,171 $1.65 Million
Q2 2021 Aug 11, 2021	SELL	$29.06 - $38.83 $314,283 - $419,946	-10,815 Reduced 17.88%	49,669 $1.44 Million
Q1 2021 May 13, 2021	SELL	$39.04 - $64.6 $52,157 - $86,305	-1,336 Reduced 2.16%	60,484 $2.61 Million
Q4 2020 Feb 09, 2021	BUY	$42.46 - $56.58 $264,228 - $352,097	6,223 Added 11.19%	61,820 $2.86 Million
Q3 2020 Nov 12, 2020	BUY	$37.44 - $64.63 $117,711 - $203,196	3,144 Added 5.99%	55,597 $2.41 Million
Q2 2020 Aug 12, 2020	BUY	$17.62 - $58.71 $45,794 - $152,587	2,599 Added 5.21%	52,453 $2.78 Million
Q1 2020 May 06, 2020	BUY	$12.26 - $41.14 $373,084 - $1.25 Million	30,431 Added 156.68%	49,854 $1.11 Million
Q3 2019 Nov 07, 2019	BUY	$7.04 - $11.77 $9,433 - $15,771	1,340 Added 7.41%	19,423 $136,000
Q2 2019 Aug 12, 2019	BUY	$8.99 - $11.79 $162,566 - $213,198	18,083 New	18,083 $198,000

3.14M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $12.6M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.